Therapeutic targets in severe hypertriglyceridemia

Drug Discovery Today: Disease Mechanisms

Volumn 1, Issue 2, 2004, Pages 171-177

  Capell, Warren H ^a   Spiegelman, Karuna P ^a   Eckel, Robert H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; CYCLOSPORIN; ESTROGEN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUASTERONE; GEMFIBROZIL; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LIPOPROTEIN LIPASE; LOOP DIURETIC AGENT; MIRTAZAPINE; NICOTINIC ACID; OLANZAPINE; OMEGA 3 FATTY ACID; PROPOFOL; RECOMBINANT INTERFERON; RETINOIC ACID; STEROID HORMONE; TACROLIMUS; TAMOXIFEN; TETRAHYDROLIPSTATIN; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; VEGETABLE OIL;

ACUTE PANCREATITIS; CLINICAL TRIAL; DIET THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; ECHIUM; FAT INTAKE; GENETIC DISORDER; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; PATIENT EDUCATION; REVIEW; STEATORRHEA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 23744453615     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2004.09.012     Document Type: Review

References (25)

1. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2000) J. Am. Med. Assoc. 285, 2486-2497
2. Ford, E.S. and Giles, W.H. (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26, 575-581
3. Brunzell, J.D. and Bierman, E.L. (1982) Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. Med. Clin. North Am. 66, 455-468
4. Brunzell, J.D. et al. (1973) Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J. Clin. Invest. 52, 1578-1585
5. Baron, T.H. and Morgan, D.E. (1999) Acute necrotizing pancreatitis. N. Engl. J. Med. 340, 1412-1417
6. Ferreira, L.D. et al. (2001) Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 50, 1064-1068
7. Kim, J.K. et al. (2001) Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. USA 98, 7522-7527
8. Yagyu, H. et al. (2003) Lipoprotein lipase (LPL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Invest. 111, 419-426
9. Staels, B. et al. (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088-2093
10. Garg, A. and Grundy, S.M. (1990) Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. J. Am. Med. Assoc. 264, 723-726
11. Santamarina-Fojo, S. (1998) The familial chylomicronemia syndrome. Endocrinol. Metab. Clin. North Am. 27, 551-567 (viii)
12. Yadav, D. and Pitchumoni, C.S. (2003) Issues in hyperlipidemic pancreatitis. J. Clin. Gastroenterol. 36, 54-62
13. Goldenberg, N.M. et al. (2003) An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin. Chim. Acta 332, 11-19
14. Illingworth, D.R. (1990) Treatment of hyperlipidaemia. Br. Med. Bull. 46, 1025-1058
15. Castagneto, M. et al. (1998) A surgical option for familial chylomicronemia associated with insulin-resistant diabetes mellitus. Obes. Surg. 8, 191-198
16. Wierzbicki, A.S. et al. (2002) Usefulness of Orlistat in the treatment of severe hypertriglyceridemia. Am. J. Cardiol. 89, 229-231
17. Tolentino, M.C. et al. (2002) Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia. Endocr. Pract. 8, 208-212
18. Schwartz, A.G. and Pashko, L.L. (2004) Biologic and therapeutic effects of dehydroepiandrosterone and structural analogs. In Cancer Chemoprevention, Volume 1: Promising Cancer Chemoprevention Agents (Kelloff, G.J., Hawk, E.T., Sigman, C.C. eds), pp. 291-300, Humana Press
19. Surette, M.E. et al. (2004) Dietary echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans. J. Nutr. 134, 1406-1411
20. Lennertz, A. et al. (1999) Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther. Apher. 3, 227-233
21. Yeh, J.H. et al. (2003) Plasmapheresis for hyperlipidemic pancreatitis. J. Clin. Apheresis 18, 181-185
22. Heaney, A.P. et al. (1999) Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy. J. Clin. Endocrinol. Metab. 84, 1203-1205
23. Donahoo, W.T. et al. (1998) Drugs causing dyslipoproteinemia. Endocrinol. Metab Clin. North Am. 27, 677-697
24. Chang, H.Y. et al. (2003) Eruptive xanthomas associated with olanzapine use. Arch. Dermatol. 139, 1045-1048
25. Chen, J.L. et al. (2003) Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report. Pharmacotherapy 23, 940-944